These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 36855829)

  • 1. Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario.
    Mazzaschi G; Giudice GC; Corianò M; Campobasso D; Perrone F; Maffezzoli M; Testi I; Isella L; Maestroni U; Buti S
    Technol Cancer Res Treat; 2023; 22():15330338231159753. PubMed ID: 36855829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview, Diagnosis, and Perioperative Systemic Therapy of Upper Tract Urothelial Carcinoma.
    Kolawa A; D'Souza A; Tulpule V
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune checkpoint inhibition in upper tract urothelial carcinoma.
    Califano G; Ouzaid I; Verze P; Hermieu JF; Mirone V; Xylinas E
    World J Urol; 2021 May; 39(5):1357-1367. PubMed ID: 33128595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of molecular profiles of upper tract urothelial carcinoma
    Tomiyama E; Fujita K; Hashimoto M; Adomi S; Kawashima A; Minami T; Yoshimura K; Uemura H; Nonomura N
    Transl Androl Urol; 2022 Dec; 11(12):1747-1761. PubMed ID: 36632153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urothelial carcinoma of the upper urinary tract].
    Kranz J; Hoffmann M; Alexa R; Kuppe C; Gaisa NT; Saar M
    Urologie; 2023 Jun; 62(6):640-650. PubMed ID: 37261485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Advances in Immune Checkpoint Inhibition and Clinical Genomics in Upper Tract Urothelial Carcinoma: State of the Art.
    Califano G; Ouzaid I; Laine-Caroff P; Peyrottes A; Collà Ruvolo C; Pradère B; Elalouf V; Misrai V; Hermieu JF; Shariat SF; Xylinas E
    Curr Oncol; 2022 Jan; 29(2):687-697. PubMed ID: 35200559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and treatment outcomes of kidney transplant recipients with de novo urothelial carcinoma: thirty years of experience from a single center.
    Du C; Zheng M; Wang Z; Zhang J; Lin J; Zhang L; Tian Y; Zhu Y
    BMC Urol; 2023 Apr; 23(1):71. PubMed ID: 37118774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy.
    Tang Q; Zuo W; Wan C; Xiong S; Xu C; Yuan C; Sun Q; Zhou L; Li X
    Front Immunol; 2022; 13():1097730. PubMed ID: 36818471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
    Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L
    Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma.
    Necchi A; Madison R; Pal SK; Ross JS; Agarwal N; Sonpavde G; Joshi M; Yin M; Miller VA; Grivas P; Chung JH; Ali SM
    Eur Urol Focus; 2021 Nov; 7(6):1339-1346. PubMed ID: 32861617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine?
    Audisio M; Tucci M; Di Stefano RF; Parlagreco E; Ungaro A; Turco F; Audisio A; Di Prima L; Ortega C; Di Maio M; Scagliotti GV; Buttigliero C
    Crit Rev Oncol Hematol; 2022 Jun; 174():103682. PubMed ID: 35421529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours.
    Yates DR; Catto JW
    World J Urol; 2013 Feb; 31(1):21-9. PubMed ID: 22986906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates and novel treatments in urothelial carcinoma.
    Hanna KS
    J Oncol Pharm Pract; 2019 Apr; 25(3):648-656. PubMed ID: 30304985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma.
    Cathomas R; Lorch A; Bruins HM; Compérat EM; Cowan NC; Efstathiou JA; Fietkau R; Gakis G; Hernández V; Espinós EL; Neuzillet Y; Ribal MJ; Rouanne M; Thalmann GN; van der Heijden AG; Veskimäe E; Alfred Witjes J; Milowsky MI;
    Eur Urol; 2022 Jan; 81(1):95-103. PubMed ID: 34742583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder.
    Yang K; Yu W; Liu H; Ding F; Zhang Y; Zhang Y; Wang W; Lou F; Cao S; Wang H; He Z
    Oncologist; 2021 Aug; 26(8):e1395-e1405. PubMed ID: 34050578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.
    Leow JJ; Chong YL; Chang SL; Valderrama BP; Powles T; Bellmunt J
    Eur Urol; 2021 May; 79(5):635-654. PubMed ID: 32798146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Knowledge on Genomic Profiling of Upper Tract Urothelial Carcinoma.
    De Lorenzis E; Albo G; Longo F; Bebi C; Boeri L; Montanari E
    Genes (Basel); 2021 Feb; 12(3):. PubMed ID: 33668859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete Pathologic Response With Pembrolizumab and Enfortumab Vedotin in Urothelial Carcinoma of the Upper Urinary Tract.
    Chan KH; Shu T; Al Shaarani M; Cen P
    J Investig Med High Impact Case Rep; 2024; 12():23247096241257333. PubMed ID: 38804541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.